149
Views
0
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

Natural progress history of asymptomatic bacterial vaginosis in Chinese Han women and associated risk factors

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 659-667 | Received 13 Mar 2022, Accepted 10 Aug 2022, Published online: 19 Aug 2022

References

  • Ruiz-Perez D, Coudray MS, Colbert B, et al. Effect of metronidazole on vaginal microbiota associated with asymptomatic bacterial vaginosis. Access Microbiol. 2021;3(5):000226.
  • Hillier SL. Diagnostic microbiology of bacterial vaginosis. Am J Obstet Gynecol. 1993;169:455–459.
  • Hardy L, Jespers V, Dahchour N, et al. Unravelling the bacterial vaginosis-associated biofilm: a multiplex gardnerella vaginalis and atopobium vaginae fluorescence in situ hybridization assay using peptide nucleic acid probes. Plos One. 2015;10:e0136658.
  • Chen HM, Chang TH, Lin FM, et al. Vaginal microbiome variances in sample groups categorized by clinical criteria of bacterial vaginosis. BMC Genomics. 2018;19:876.
  • Puran AC, Adler D, Wallace M, et al. Incidental Findings of Bacterial Vaginosis and Other Infections in Papanicolaou Smears of HIV-infected and HIV-uninfected Adolescent Females in South Africa. J AIDS HIV Res. 2014;6(9):172–176.
  • Smith WL, Hedges SR, Mordechai E, et al. Cervical and vaginal flora specimens are highly concordant with respect to bacterial vaginosis-associated organisms and commensal Lactobacillus species in women of reproductive age. J Clin Microbiol. 2014;52(8):3078–3081.
  • Francis SC, Looker C, Vandepitte J, et al. Bacterial vaginosis among women at high risk for HIV in Uganda: high rate of recurrent diagnosis despite treatment. Sex Transm Infect. 2016;92:142–148.
  • O’Hanlon DE, Gajer P, Brotman RM, et al. Asymptomatic bacterial vaginosis is associated with depletion of mature superficial cells shed from the vaginal epithelium. Front Cell Infect Microbiol. 2020;10:106.
  • Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis. 2007;34(11):864–869.
  • Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74:14–22.
  • Mlisana K, Naicker N, Werner L, et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis. 2012;206:6–14.
  • Pramanick R, Mayadeo N, Warke H, et al. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: are they different from normal microbiota. Microb Pathog. 2019;134:103599.
  • Joyisa N, Moodley D, Nkosi T, et al. Asymptomatic bacterial vaginosis in pregnancy and missed opportunities for treatment: a cross-sectional observational study. Infect Dis Obstet Gynecol 2019 7808179 10.1155/2019/7808179
  • Dabee S, Passmore JS, Heffron R, et al. The complex link between the female genital microbiota, genital infections, and inflammation. Infect Immun. 2021;89(5). DOI:10.1128/IAI.00487-20
  • Schwebke JR, Desmond R. Natural history of asymptomatic bacterial vaginosis in a high-risk group of women. Sex Transm Dis. 2007;34(11):876–877.
  • Schwebke JR, Desmond RA. A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis. Clin Infect Dis. 2007;44(2):213–219.
  • Fleury FJ. The clinical signs and symptoms of Gardnerella-associated vaginosis. Scand J Infect Dis Suppl. 1983;40:71–72.
  • Eschenbach DA, Hillier S, Critchlow C, et al. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol. 1988;158:819–828.
  • Li T, Liu ZH, Li K, et al. Evaluation of the vaginal microbiome in clinical diagnosis and management of vaginal infectious diseases. Chin Med J (Engl). 2019;132:1100–1103.
  • Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297–301.
  • Fregosi NJ, Hobson D, Kinman CL, et al. Changes in the vaginal microenvironment as related to frequency of pessary removal. Female Pelvic Med Reconstr Surg. 2018;24:166–171.
  • Hopkins MJ, Ashton LJ, Alloba F, et al. Validation of a laboratory-developed real-time PCR protocol for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine. Sex Transm Infect. 2010;86:207–211.
  • Baisley KJ, Andreasen A, Irani J, et al. HPV prevalence around the time of sexual debut in adolescent girls in Tanzania. Sex Transm Infect. 2020;96:211–219.
  • Qi W, Li H, Wang C, et al. Recent advances in presentation, diagnosis and treatment for mixed vaginitis. Front Cell Infect Microbiol. 2021;11:759795.
  • Sobel JD, Subramanian C, Foxman B, et al. Mixed vaginitis-more than coinfection and with therapeutic implications. Curr Infect Dis Rep. 2013;15(2):104–108.
  • Gibbs RS. Asymptomatic bacterial vaginosis: is it time to treat. Am J Obstet Gynecol. 2007;196(6):495–496.
  • Lewis AL, Laurent LC. USPSTF 2020 recommendations on screening for asymptomatic bacterial vaginosis in pregnancy. JAMA. 2020;323(13):1253–1255.
  • Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187.
  • Muzny CA, Schwebke JR. Asymptomatic bacterial vaginosis: to treat or not to treat. Curr Infect Dis Rep. 2020;22(12). DOI:10.1007/s11908-020-00740-z
  • Schwebke JR. Asymptomatic bacterial vaginosis: response to therapy. Am J Obstet Gynecol. 2000;183(6):1434–1439.
  • Schwebke JR, Desmond R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol. 2007;196(6):517.e1–6.
  • Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol. 2006;194:1283–1289.
  • Kahwati LC, Clark R, Berkman N, et al. Screening for bacterial vaginosis in pregnant adolescents and women to prevent preterm delivery: updated evidence report and systematic review for the us preventive services task force. JAMA. 2020;323:1293–1309.
  • Bradshaw CS, Sobel JD. Current treatment of bacterial vaginosis-limitations and need for innovation. J Infect Dis. 2016;214 Suppl 1:S14–20.
  • Atashili J, Poole C, Ndumbe PM, et al. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008;22(12):1493–1501.
  • Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis. 1999;180:1863–1868.
  • Brotman RM, Klebanoff MA, Nansel TR, et al. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis. 2010;202(12):1907–1915.
  • Brusselaers N, Shrestha S, van de Wijgert J, et al. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am J Obstet Gynecol. 2019;221(1):9–18.e8.
  • Abbai NS, Nyirenda M, Naidoo S, et al. Prevalent herpes simplex virus-2 increases the risk of incident bacterial vaginosis in women from South Africa. AIDS Behav. 2018;22(7):2172–2180.
  • Wiesenfeld HC, Hillier SL, Krohn MA, et al. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis. 2003;36(5):663–668.
  • Kissinger P, Muzny CA, Mena LA, et al. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial. Lancet Infect Dis. 2018;18(11):1251–1259.
  • Ness RB, Kip KE, Hillier SL, et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol. 2005;162(6):585–590.
  • van Oostrum N, De Sutter P, Meys J, et al. Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis. Hum Reprod. 2013;28(7):1809–1815.
  • Haggerty CL, Hillier SL, Bass DC, et al. PID evaluation and clinical health study investigators. bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin Infect Dis. 2004;39:990–995.
  • Afolabi BB, Moses OE, Oduyebo OO. Bacterial vaginosis and pregnancy outcome in Lagos, Nigeria. Open Forum Infect Dis. 2016;3:ofw030.
  • Das TR, Jahan S, Begum SR, et al. Association between bacterial vaginosis and preterm delivery. Mymensingh Med J. 2011;20:115–120.
  • Işik G, Demirezen Ş, Dönmez HG, et al. Bacterial vaginosis in association with spontaneous abortion and recurrent pregnancy losses. J Cytol. 2016;33:135–140.
  • Wenman WM, Tataryn JMR IV, Joffres MR, et al. Demographic, clinical and microbiological characteristics of maternity patients: a Canadian clinical cohort study. Can J Infect Dis. 2002;13:311–318.
  • Mullick S, Watson-Jones D, Beksinska M, et al. Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect. 2005;81:294–302.
  • Kamga YM, Ngunde JP, Akoachere J. Prevalence of bacterial vaginosis and associated risk factors in pregnant women receiving antenatal care at the Kumba Health District (KHD), Cameroon. BMC Pregnancy Childbirth. 2019;19:166.
  • Bradshaw CS, Vodstrcil LA, Hocking JS, et al. Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clin Infect Dis. 2013;56(6):777–786.
  • Mehta SD, Nannini DR, Otieno F, et al. Host genetic factors associated with vaginal microbiome composition in Kenyan Women. mSystems. 2020;5(4). DOI:10.1128/mSystems.00502-20.
  • Beksinska M, Wong R, Smit J. Male and female condoms: their key role in pregnancy and STI/HIV prevention. Best Pract Res Clin Obstet Gynaecol. 2020;66:55–67.
  • Apter D. Contraception options: aspects unique to adolescent and young adult. Best Pract Res Clin Obstet Gynaecol. 2018;48:115–127.
  • Mitchell CM, Srinivasan S, Ma N, et al. Bacterial communities associated with abnormal Nugent score in postmenopausal versus premenopausal women. J Infect Dis. 2021;223(12):2048–2052.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.